Zydus Cadila's "Virafin" Approved For Treating Moderate Covid Cases
- 227
- 2
-
- Last Comment
DCGI on Friday granted emergency use approval for Zydus Cadila’s Pegylated Interferon alpha-2b, ‘Virafin’, for treating moderate COVID-19 infection in adults.
According to the pharmaceutical firm, a single dose of the anti-viral Virafin administered subcutaneously early on shows significant clinical and virological improvement in moderate COVID-19 adult patients.
“91.5 per cent of patients treated with PegIFN were RT-PCR negative by day 7,” the pharma major mentioned on its Twitter account.
The firm also says that the treatment significantly reduces the hours of supplemental oxygen required for COVID-19 patients.
1 Comment
|
2 Dimers
- Sort By
Click here to reply
Reply
![](https://www.pinterest.com/pin/create/button/?url=https%3A%2F%2Fwww.desidime.com%2Fdiscussions%2Fzydus-cadila-s-virafin-approved-for-treating-moderate-covid-cases%3Futm_campaign%3DDDUserReferral%26utm_medium%3Dpinterest%26utm_source%3Dreferral&media=https://cdn2.desidime.com/topics/photos/1283514/small/c_tnplaceholder.png?1619184000&description=Zydus Cadila's "Virafin" Approved For Treating Moderate Covid Cases for Rs. at ){kind=link}
Ab iski shortage hogi 😪